Abstract: An hydroxypropyl-aziridine-containing side chain is attached to an oxonaphthalene-annelated pyrrole in expectation of DNA alkylating properties. The cytotoxicity is evaluated against two cell lines, KB-31 and KB-8511, respectively.
Introduction
Chlorambucil and melphalan are chemotherapy drugs belonging to the class of nitrogen mustard alkylating agents. Both compounds are believed to exert their antitumor effects by cross-linking DNA via aziridinium cation intermediates arising from the bis(2-chloroethyl)amine moiety [1] . Besides that there are anticancer agents with the aziridine moiety, such as TEPA, thio-TEPA and triethylenemelamine with a 1,3,5-triazine nucleus. In continuation of our department's previous studies in the field of antitumor agents [2] [3] [4] [5] [6] [7] [8] [9] [10] , we are reporting in this paper the synthesis of the oxonaphthalene-annelated pyrrole 2 with an attached side chain containing an aziridine group. The rationale is that the three-membered aziridine ring is struturally analogous to the immoniumintermediate formed from the nitrogen mustards. The aziridine moietiy is not charged and the reactivity results from the strain on the three-member ring structure [11] . Recent studies with aziridine substituted quinones showed promising results against breast cancer tumor cells [12, 13] . The cytotoxic activity of 2 was evaluated.
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Reaction of 1 [14] with 2-(chloromethyl)oxirane with KOH in DMSO [15] afforded the N-alkylated product. The following reaction with aziridine [16] gave the target compound 2 (Scheme 1). The biological activity of 2 was tested against two cancer cell lines, KB-31 and KB-8511, respectively. KB-31 is a drug sensitive human epidermoid cell line, whereas KB-8511 is a multi-drug resistant subline, typically overexpressing P-glycoprotein. The IC 50 [µM] values of 2 are 9.362 (KB-31) and 6.452 (KB-8511), respectively (3 days incubation time; staining with 0.05% methylene blue; optical density measured at 665 nm; for further experimental details, see [17, 18] ). 
2-[3-(Aziridin-1-yl)-2-hydroxypropyl]-5,5-dimethyl-2,5-dihydro-4H-benzo[e]isoindol-4-one (2)
(a) To a solution of 1 [12] (0.5 g, 2.37 mmol) in 4.7 mL of dry DMSO were added at room temperature dropwise under argon 1.5 mL (18.96 mmol) of 2-(chloromethyl)oxirane. Subsequently 0.265 g (4.74 mmol) of KOH were added and stirring was continued for 2 h at room temperature. The reaction mixture was diluted with 9.5 ml of H 2 O, extracted with CH 2 Cl 2 , dried (Na 2 SO 4 ), concentrated in vacuo and isolated after column chromatography (silica gel, ethyl acetate/light petroleum 70/30). Yield 284 mg (45%) of a colorless oil.
(b) The resulting product (284 mg) was dissolved in 4.6 ml EtOH (1% TEA) and after the addition of 0.37 mL (7.2 mmol) of aziridine under argon the reaction mixture was refluxed for 1 h. After concentration in vacuo the resulting crude product was purified by column chromatography (silica gel, ethyl acetate/ethanol 95/5) to afford 104 mg (32%) of colorless crystals of 2. m. 
